Bayer HealthCare asked Origin to develop a tradename for telmisartan, an innovative treatment for hypertension, to be marketed in selected European countries.

The impactful and graphically distinctive Kinzal was selected for its brevity and ease of pronunciation. The brand is known variously as Kinzal, Kinzalmono and Kinzalkomb, dependant upon formulation and target patient group.